Back to Search
MARY VAN DEN BERG-WOLF, MD
MD
Internal Medicine Physician
NPI: 1114915147Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD60806378(WA)MD025054E(PA)
Research & Publications (6)
Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients.
PMID 18462073·AIDS Patient Care STDS·2008
8-other
Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients.
PMID 19635261·Am J Med·2009
8-other
Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study).
PMID 18176329·J Acquir Immune Defic Syndr·2008
2-rct
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
PMID 17174704·Lancet·2006
4-observational
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
PMID 15668873·Clin Infect Dis·2005
2-rct
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial.
PMID 11306155·Control Clin Trials·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 225 E CITY AVE, SUITE 109
BALA CYNWYD, PA 19004 - Phone
- (215) 503-3838
Quick Facts
- NPI
- 1114915147
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile